{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:44:52Z","timestamp":1793119492114,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH\/NCI Cancer Center","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"DOI":"10.13039\/501100012331","name":"Leo Foundation","doi-asserted-by":"publisher","award":["#LF18045"],"award-info":[{"award-number":["#LF18045"]}],"id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.addr.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T08:24:48Z","timestamp":1578385488000},"page":"185-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Ablative fractional laser-assisted treatments for keratinocyte carcinomas and its precursors\u2013Clinical review and future perspectives"],"prefix":"10.1016","volume":"153","author":[{"given":"Andr\u00e9s M.","family":"Erlendsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uffe H.","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Haedersdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.addr.2020.01.001_bb0005","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the us population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.addr.2020.01.001_bb0010","series-title":"Natl Compr Cancer Netw. 2019","author":"NCCN Guidelines Basal Cell Skin Cancer Version 1","year":"2019"},{"issue":"10","key":"10.1016\/j.addr.2020.01.001_bb0015","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa1811850","article-title":"Randomized trial of four treatment approaches for actinic keratosis","volume":"380","author":"Jansen","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.addr.2020.01.001_bb0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/M18-0678","article-title":"Treatments of primary basal cell carcinoma of the skin","volume":"169","author":"Drucker","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.addr.2020.01.001_bb0025","series-title":"Drug Delivery Devices: Fundamentals and Applications","first-page":"385","article-title":"Transdermal drug delivery systems","author":"Govil","year":"1988"},{"key":"10.1016\/j.addr.2020.01.001_bb0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2014.05.022","article-title":"Transdermal drug delivery: 30+ years of war and still fighting!","volume":"190","author":"Wiedersberg","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.01.001_bb0035","series-title":"Dermatological and Transdermal Formulations","first-page":"401","article-title":"Bioavailability and bioequivalence dermatological formulations","volume":"119","author":"Surber","year":"2002"},{"issue":"4","key":"10.1016\/j.addr.2020.01.001_bb0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jamadermatol.2016.5268","article-title":"Comparison of physical pretreatment regimens to enhance protoporphyrin IX uptake in photodynamic therapy","volume":"153","author":"Bay","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"2","key":"10.1016\/j.addr.2020.01.001_bb0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/lsm.20405","article-title":"Ex vivo histological characterization of a novel ablative fractional resurfacing device","volume":"39","author":"Hantash","year":"2007","journal-title":"Lasers Surg. Med."},{"issue":"5","key":"10.1016\/j.addr.2020.01.001_bb0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jaad.2015.12.008","article-title":"Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status","volume":"74","author":"Haedersdal","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.addr.2020.01.001_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/lsm.20860","article-title":"Fractional CO(2) laser-assisted drug delivery","volume":"42","author":"Haedersdal","year":"2010","journal-title":"Lasers Surg. Med."},{"issue":"8","key":"10.1016\/j.addr.2020.01.001_bb0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/lsm.21096","article-title":"Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment","volume":"43","author":"Haedersdal","year":"2011","journal-title":"Lasers Surg. Med."},{"issue":"10","key":"10.1016\/j.addr.2020.01.001_bb0065","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/lsm.22102","article-title":"Fractional laser-assisted delivery of methyl aminolevulinate: impact of laser channel depth and incubation time","volume":"44","author":"Haak","year":"2012","journal-title":"Lasers Surg. Med."},{"issue":"6","key":"10.1016\/j.addr.2020.01.001_bb0070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/lsm.22259","article-title":"Pretreatment with ablative fractional laser changes kinetics and biodistribution of topical 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL)","volume":"46","author":"Haedersdal","year":"2014","journal-title":"Lasers Surg. Med."},{"issue":"9","key":"10.1016\/j.addr.2020.01.001_bb0075","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1600-0625.2010.01093.x","article-title":"Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation","volume":"19","author":"Forster","year":"2010","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2020.01.001_bb0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jphotobiol.2016.03.021","article-title":"Ablative fractional laser enhances MAL-induced PpIX accumulation: impact of laser channel density, incubation time and drug concentration","volume":"159","author":"Haak","year":"2016","journal-title":"J. Photochem. Photobiol. B Biol."},{"issue":"12","key":"10.1016\/j.addr.2020.01.001_bb0085","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/exd.13068","article-title":"Ablative non-sequential fractional ultrapulsed CO2 laser pretreatment improves conventional photodynamic therapy with methyl aminolevulinate in a novel human in vitro 3D actinic keratosis skin model","volume":"25","author":"Huth","year":"2016","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.addr.2020.01.001_bb0090","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/17425247.2017.1260119","article-title":"Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake","volume":"14","author":"Wenande","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.addr.2020.01.001_bb0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2011.03.015","article-title":"Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules","volume":"153","author":"Lee","year":"2011","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.addr.2020.01.001_bb0100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00403-015-1561-3","article-title":"Ablative fractional laser alters biodistribution of ingenol mebutate in the skin","volume":"307","author":"Erlendsson","year":"2015","journal-title":"Arch. Dermatol. Res."},{"issue":"3","key":"10.1016\/j.addr.2020.01.001_bb0105","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ejpb.2011.03.006","article-title":"Using laser microporation to improve transdermal delivery of diclofenac: increasing bioavailability and the range of therapeutic applications","volume":"78","author":"Bachhav","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.addr.2020.01.001_bb0110","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/bjd.12507","article-title":"Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands","volume":"169","author":"Helsing","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2020.01.001_bb0115","series-title":"World Health Organization - General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine","author":"Zhang","year":"2000"},{"issue":"6","key":"10.1016\/j.addr.2020.01.001_bb0120","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2133.2012.10893.x","article-title":"Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial","volume":"166","author":"Togsverd-Bo","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.addr.2020.01.001_bb0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5021\/ad.2013.25.4.417","article-title":"Photodynamic therapy with ablative carbon dioxide fractional laser in treatment of actinic keratosis","volume":"25","author":"Jang","year":"2013","journal-title":"Ann. Dermatol."},{"issue":"2","key":"10.1016\/j.addr.2020.01.001_bb0130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bjd.13222","article-title":"Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial","volume":"172","author":"Togsverd-Bo","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"11","key":"10.1016\/j.addr.2020.01.001_bb0135","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/jdv.12334","article-title":"Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study","volume":"28","author":"Ko","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"8","key":"10.1016\/j.addr.2020.01.001_bb0140","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/jdv.12953","article-title":"Efficacy of ablative fractional laser-assisted photodynamic therapy with short-incubation time for the treatment of facial and scalp actinic keratosis: 12-month follow-up results of a randomized, prospective, comparative trial","volume":"29","author":"Choi","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"6","key":"10.1016\/j.addr.2020.01.001_bb0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/phpp.12184","article-title":"Fractional carbon dioxide laser-assisted photodynamic therapy for patients with actinic keratosis","volume":"31","author":"Song","year":"2015","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.addr.2020.01.001_bb0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pdpdt.2017.01.184","article-title":"Efficacy of iontophoresis-assisted ablative fractional laser photodynamic therapy with short incubation time for the treatment of actinic keratosis: 12-month follow-up results of a prospective, randomised, comparative trial","volume":"18","author":"Choi","year":"2017","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"4","key":"10.1016\/j.addr.2020.01.001_bb0155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jaad.2017.11.027","article-title":"Topical calcipotriol before ablative fractional laser-assisted photodynamic therapy enhances treatment outcomes for actinic keratosis in Fitzpatrick grades III-V skin: a prospective randomized clinical trial","volume":"78","author":"Seo","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.01.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.01.033","article-title":"A comparison of the efficacy of ablative fractional laser assisted photodynamic therapy according to ablative depth for actinic keratosis: a single-blinded, randomized, comparative, prospective study","author":"Seo","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.addr.2020.01.001_bb0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bjd.17096","article-title":"Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization","volume":"180","author":"Wenande","year":"2019","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.addr.2020.01.001_bb0170","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/DSS.0000000000001117","article-title":"Randomized, controlled trial of fractional carbon dioxide laser resurfacing followed by ultrashort incubation aminolevulinic acid blue light photodynamic therapy for actinic keratosis","volume":"43","author":"Alexiades","year":"2017","journal-title":"Dermatol. Surg."},{"issue":"3","key":"10.1016\/j.addr.2020.01.001_bb0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/1721727X16674219","article-title":"Ablative fractional laser improves treatment of actinic keratoses with Ingenol Mebutate","volume":"14","author":"Nistic\u00f2","year":"2016","journal-title":"Eur. J. Inflamm."},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14302\/issn.2471-2175.jdrt-14-552","article-title":"The combination of fractionated erbium:YAG laser skin microporation and topical imiquimod is a new, safe and efficient strategy for the treatment of actinic keratosis and basal cell carcinoma: report of two pilot studies. Chernyshov P, ed","volume":"1","author":"Haering","year":"2015","journal-title":"J. Dermatol. Res. Ther."},{"issue":"5","key":"10.1016\/j.addr.2020.01.001_bb0185","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","article-title":"A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck","volume":"24","author":"Olsen","year":"1991","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.01.001_bb0190","article-title":"A comparison of the efficacy of ablative fractional laser-assisted photodynamic therapy according to the density of ablative laser channel in the treatment of actinic keratosis: a prospective, randomized, controlled trial","author":"Cho","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjd.12627","article-title":"A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up","volume":"170","author":"Ko","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.addr.2020.01.001_bb0200","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5021\/ad.2013.25.3.335","article-title":"Photodynamic therapy with ablative carbon dioxide fractional laser for treating bowen disease","volume":"25","author":"Kim","year":"2013","journal-title":"Ann. Dermatol."},{"issue":"11","key":"10.1016\/j.addr.2020.01.001_bb0205","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/jdv.14989","article-title":"Laser-assisted photodynamic therapy for superficial basal cell carcinoma and Bowen\u2019s disease: a randomized intrapatient comparison between a continuous and a fractional ablative CO 2 laser mode","volume":"32","author":"Genouw","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.addr.2020.01.001_bb0210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaad.2018.05.034","article-title":"Ablative fractional laser\u2013assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease","volume":"79","author":"Kim","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.addr.2020.01.001_bb0215","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaad.2014.11.033","article-title":"Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil","volume":"72","author":"Nguyen","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.addr.2020.01.001_bb0220","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/DSS.0000000000000814","article-title":"Ablative fractional laser\u2013assisted topical fluorouracil for the treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ: a follow-up study","volume":"42","author":"Hsu","year":"2016","journal-title":"Dermatol. Surg."},{"issue":"3","key":"10.1016\/j.addr.2020.01.001_bb0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jamadermatol.2016.4463","article-title":"Effect of methyl aminolevulinate photodynamic therapy with and without ablative fractional laser treatment in patients with microinvasive squamous cell carcinoma","volume":"153","author":"Choi","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"8","key":"10.1016\/j.addr.2020.01.001_bb0230","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/dsu.12242","article-title":"Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate","volume":"39","author":"Lippert","year":"2013","journal-title":"Dermatol. Surg."},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bjd.13166","article-title":"Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas \u2013 a randomized clinical trial","volume":"172","author":"Haak","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.addr.2020.01.001_bb0240","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jdv.13453","article-title":"Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial","volume":"30","author":"Choi","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.addr.2020.01.001_bb0245","article-title":"Laser-assisted photodynamic therapy for actinic keratosis: a systematic review and meta-analysis","author":"Steeb","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2020.01.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/lsm.23088","article-title":"Drug penetration enhancement techniques in ablative fractional laser assisted cutaneous delivery of indocyanine green","author":"Meesters","year":"2019","journal-title":"Lasers Surg. Med."},{"issue":"2","key":"10.1016\/j.addr.2020.01.001_bb0255","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/lsm.22374","article-title":"Fractional laser-assisted drug delivery: active filling of laser channels with pressure and vacuum alteration","volume":"48","author":"Erlendsson","year":"2016","journal-title":"Lasers Surg. Med."},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0260","first-page":"14","article-title":"Fractional ablative laser followed by transdermal acoustic pressure wave device to enhance the drug delivery of aminolevulinic acid: in vivo fluorescence microscopy study","volume":"15","author":"Waibel","year":"2016","journal-title":"J. Drugs Dermatol."},{"issue":"11","key":"10.1016\/j.addr.2020.01.001_bb0265","first-page":"1191","article-title":"Randomized, double-blind, split-face study evaluating fractional ablative erbium:YAG laser-mediated trans-epidermal delivery of cosmetic actives and a novel acoustic pressure wave ultrasound technology for the treatment of skin aging, melasma, and acne Sc","volume":"14","author":"Alexiades","year":"2015","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.addr.2020.01.001_bb0270","author":"European Medicines Agency"},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0275","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI89820","article-title":"Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy","volume":"127","author":"Cunningham","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13095-8","article-title":"Fractional laser releases tumor-associated antigens in poorly immunogenic tumor and induces systemic immunity","volume":"7","author":"Kawakubo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2020.01.001_bb0285","article-title":"Topical ablative fractional laser-assisted delivery of cisplatin + 5-FU for basal cell carcinoma: an explorative, open-label clinical trial","volume":"51","author":"Wenande","year":"2019","journal-title":"Lasers Surg. Med."},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2011.07.024","article-title":"Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies","volume":"156","author":"Yu","year":"2011","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0295","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36966-0","article-title":"Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody \u2013 OS2966","volume":"9","author":"Lapteva","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0300","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/10717544.2019.1574937","article-title":"Fractional laser-assisted topical delivery of bleomycin quantified by LC-MS and visualized by MALDI mass spectrometry imaging","volume":"26","author":"Hendel","year":"2019","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.addr.2020.01.001_bb0305","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1517\/17425247.2015.1031216","article-title":"Topically applied methotrexate is rapidly delivered into skin by fractional laser ablation","volume":"12","author":"Taudorf","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0310","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1080\/10717544.2018.1534896","article-title":"Laser-assisted delivery enhances topical uptake of the anticancer agent cisplatin","volume":"25","author":"Wenande","year":"2018","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0315","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/lsm.23013","article-title":"Topical delivery of vismodegib using ablative fractional laser and micro-emulsion formulation in vitro","volume":"51","author":"Olesen","year":"2019","journal-title":"Lasers Surg. Med."},{"issue":"9","key":"10.1016\/j.addr.2020.01.001_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184852","article-title":"Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response","volume":"12","author":"Kawakubo","year":"2017","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.addr.2020.01.001_bb0325","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1080\/02656736.2018.1446221","article-title":"Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumour immunogenicity","volume":"34","author":"Luo","year":"2018","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2020.01.001_bb0330","article-title":"Immunogenic cell death in cancer therapy: present and emerging inducers","author":"Zhou","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.addr.2020.01.001_bb0335","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-319-22536-4_8","article-title":"Heat-based tumor ablation: role of the immune response","volume":"880","author":"Wu","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.addr.2020.01.001_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/lsm.22228","article-title":"Fractional ablative erbium YAG laser: histological characterization of relationships between laser settings and micropore dimensions","volume":"46","author":"Taudorf","year":"2014","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.addr.2020.01.001_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2019.04.010","article-title":"5-aminolevulinic acid photodynamic therapy with and without Er:YAG laser for actinic keratosis: changes in immune infiltration","author":"Gellen","year":"2019","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.addr.2020.01.001_bb0350","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/jid.2013.276","article-title":"Mutational landscape of basal cell carcinomas by whole-exome sequencing","volume":"134","author":"Jayaraman","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.addr.2020.01.001_bb0355","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2340\/00015555-2440","article-title":"Immunosuppressive environment in basal cell carcinoma: the role of regulatory T cells","volume":"96","author":"Omland","year":"2016","journal-title":"Acta Derm. Venereol."},{"issue":"14","key":"10.1016\/j.addr.2020.01.001_bb0360","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1158\/1078-0432.CCR-09-3136","article-title":"Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas","volume":"16","author":"Walter","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2020.01.001_bb0365","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"17","key":"10.1016\/j.addr.2020.01.001_bb0370","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s40265-018-1012-5","article-title":"Cemiplimab: first global approval","volume":"78","author":"Markham","year":"2018","journal-title":"Drugs."},{"issue":"6","key":"10.1016\/j.addr.2020.01.001_bb0375","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125476","article-title":"Skin cancer precursor immunotherapy for squamous cell carcinoma prevention","volume":"4","author":"Rosenberg","year":"2019","journal-title":"JCI Insight."},{"key":"10.1016\/j.addr.2020.01.001_bb0380","series-title":"European Handbook of Dermatological Treatments","author":"Marini","year":"2015"},{"issue":"4","key":"10.1016\/j.addr.2020.01.001_bb0385","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/lsm.1900090404","article-title":"Er:YAG laser ablation of tissue: measurement of ablation rates","volume":"9","author":"Walsh","year":"1989","journal-title":"Lasers Surg. Med."},{"issue":"2","key":"10.1016\/j.addr.2020.01.001_bb0390","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3109\/10717544.2014.935532","article-title":"Permeation enhancer strategies in transdermal drug delivery","volume":"23","author":"Marwah","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2020.01.001_bb0395","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2018.02.019","article-title":"Laser-assisted delivery of synergistic combination chemotherapy in in vivo skin","volume":"275","author":"Wenande","year":"2018","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.addr.2020.01.001_bb0400","first-page":"358","article-title":"From oral to topical delivery - an in vivo study of sustained cutaneous release of vismodegib using ablative fractional laser and micro-emulsion vehicle","volume":"50","author":"Olesen","year":"2018","journal-title":"Lasers Surg. Med."},{"issue":"12","key":"10.1016\/j.addr.2020.01.001_bb0405","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1158\/1078-0432.CCR-12-0568","article-title":"Vismodegib","volume":"18","author":"Rudin","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2020.01.001_bb0410","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cis.2006.05.014","article-title":"Microemulsions as transdermal drug delivery vehicles","volume":"123\u2013126","author":"Kogan","year":"2006","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2020.01.001_bb0415","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"Muller","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2020.01.001_bb0420","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2019.03.003","article-title":"Liposomes for delivery of antioxidants in cosmeceuticals: challenges and development strategies","volume":"300","author":"Van Tran","year":"2019","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.addr.2020.01.001_bb0425","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget."},{"issue":"11","key":"10.1016\/j.addr.2020.01.001_bb0430","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/lary.26629","article-title":"Systemic therapy for head and neck squamous cell carcinoma: historical perspectives and recent breakthroughs","volume":"127","author":"Blasco","year":"2017","journal-title":"Laryngoscope."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X2030003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X2030003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:47:19Z","timestamp":1759207639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X2030003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":86,"alternative-id":["S0169409X2030003X"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2020.01.001","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ablative fractional laser-assisted treatments for keratinocyte carcinomas and its precursors\u2013Clinical review and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}